This session highlights advances that translate immunological discoveries into clinical applications. It includes preclinical research, clinical trials, biomarker development, drug discovery, artificial intelligence, digital health, advanced laboratory platforms, computational immunology, and new technologies supporting diagnosis, treatment, and disease monitoring.
Abstract Scope and Participation
Abstracts may present early-stage discoveries, trial outcomes, real-world studies, innovative tools, regulatory considerations, implementation research, and industry–academic collaborations. The session welcomes clinicians, scientists, trial investigators, data specialists, biotechnology and pharmaceutical professionals, engineers, and healthcare innovators advancing the future of immunology.
Submit your abstract Today
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation